Merck shares seen rising on growth: Barron's
473365
Merck & Co. Inc.  shares could  rise to $70 by 2010 if the drugmaker continues to deliver on  its promise of double-digit earnings growth, Barron's said in  its October 29 edition.
227799
Drugmakers Merck & Co.  and Schering-Plough Corp.  reported second-quarter results that handily topped Wall Street expectations on Monday, helped by increased sales of the cholesterol-lowering drugs they co-market and other medicines.
604801
U.S. stocks rose Monday on strong Merck & Co. profits and news of a nearly $18 billion oil services takeover, while Treasury bonds eased as reduced fears about the subprime credit market made riskier assets attractive again.
723270
Wall Street futures crept higher in pre-market trading on Tuesday as the price of oil continued its slide and investors assessed the merits of possible acquisition of cardiac-stent maker Guidant by Johnson &amp; Johnson.
627029
Shares of Nastech Pharmaceutical Co.  Inc. jumped as much as 43 percent on Monday after it said it  formed an alliance with Merck & Co. to develop its  appetite-regulating treatment for obesity.
349051
Shares of drugmaker Merck & Co. Inc.  traded 1.52 percent higher on volume of more than 61,000 shares in pre-market dealings on Friday, a day after the stock plunged to an eight-year low after the company withdrew its arthritis drug Vioxx.
747292
NEW YORK - U.S. stocks are seen opening higher at the open Tuesday after a slight gain in Monday's session...
392641
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, based on early revenue indications from a range of products, sending its shares up nearly 3 percent in early electronic trading.
469017
Merck & Co.  said on Monday that quarterly earnings rose 12 percent on strong demand for its newer vaccines and medicines, and raised its 2007 profit forecast, sending its shares up 4 percent.
329654
U.S. stock indexes gained on Monday as takeover news and strong profits from large-cap companies, such as Merck & Co. , reassured investors after a broad sell-off at the end of last week.
109221
Stocks edged up on Thursday after higher-than-expected earnings from companies, including Bear Stearns and Costco, but climbing oil prices could keep gains in check.
647804
U.S. stocks should maintain their 3  1/2-year highs this week as they ring out 2004, helped by  investor interest in large-cap stocks and a steady rebound in  beaten-down drug companies.
670575
U.S. shares looked set to open higher on   Thursday, extending Wednesday's gains after relatively dovish   comments from Federal Reserve policy makers, but worries about   the extent of the U.S. slowdown may cap equity buying.
731512
Sock index futures rose on Tuesday after news of a proposed acquisition of a health-care company, while bond yields held steady, giving investors a break from interest-rate worries.
465314
Wall Street was expected to rise on  Tuesday as easing crude oil prices soothed fears of a squeeze  on earnings and on a thin corporate menu investors will be able  to chew over results from food group H.J. Heinz Co HNZ.N.
356134
Merck & Co  on Monday said its  third-quarter profit rose sharply, helped by sales of its  vaccines and cholesterol drugs, and raised its 2007 profit  forecast in view of strong current trends.
728893
Shares of Nastech Pharmaceutical Co. Inc. (NSTK.O: Quote, Profile, Research) jumped 23 percent before the bell on Monday after the company said it tied up with Merck &amp; Co.